Leerink Partners analyst Lili (Aurélie) Nsongo has reiterated their bullish stance on ARCT stock, giving a Buy rating on October 1.

In line with the event’s theme of Driving Exploration and Development Towards Increased Production in Angola, the AOG 2024 awards celebrate the milestones, projects and progress of companies across ...

Be prepared for the most spectacular cometary visitor for northern climes since Comet Hale-Bopp in 1997, Nigel Henbest writes ...

A new star is set to appear in our sky any day now in a ‘once-in-a-lifetime’ astronomical event. Scientists are waiting with ...

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) today and set a price target of ...

Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...

Also on October evenings, standing high in the east-southeast is the most distinctive landmark of autumn nights: the Great ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

Venus still hovers low in the southwestern sky at dusk a half-hour to 45 minutes after sunset. Saturn is comfortably high up ...

A “new star” was forecasted to appear in our night sky in September, but it hasn’t been spotted yet. So where is it?